Cannaisseur Group Inc. (TCRG) stock
TCRGOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$0.06+0.06 (+1233.33%)
Close on Aug 5, 2026Market cap $3.63MP/E –Yield –
Cannaisseur operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Cannaisseur's operating income for the twelve months ending Jun 30, 2026 was -$988.97K. For fiscal 2025 it was -$1.72M.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$1.72M | – |
| FY2024 | Dec 31, 2024 | -$1.27M | – |
| FY2023 | Dec 31, 2023 | -$189.90K | – |
| FY2022 | Dec 31, 2022 | -$91.90K | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$94.83K | – |
| Q1 FY2026 | Mar 31, 2026 | -$102.26K | – |
| Q4 FY2025 | Dec 31, 2025 | -$101.40K | – |
| Q3 FY2025 | Sep 30, 2025 | -$690.48K | – |
| Q2 FY2025 | Jun 30, 2025 | -$77.49K | – |
| Q1 FY2025 | Mar 31, 2025 | -$847.07K | – |
| Q4 FY2024 | Dec 31, 2024 | -$89.39K | – |
| Q3 FY2024 | Sep 30, 2024 | -$21.34K | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.07M | – |
| Q1 FY2024 | Mar 31, 2024 | -$85.79K | – |
| Q4 FY2023 | Dec 31, 2023 | -$60.29K | – |
| Q3 FY2023 | Sep 30, 2023 | -$54.48K | – |
| Q2 FY2023 | Jun 30, 2023 | -$43.59K | – |
| Q1 FY2023 | Mar 31, 2023 | -$31.55K | – |
| Q4 FY2022 | Dec 31, 2022 | -$37.29K | – |
| Q3 FY2022 | Sep 30, 2022 | -$41.60K | – |
See a number that looks wrong?